WinstonWınston
Back
Kemira Oyj logo

Kemira Oyj

KEMIRA.HE
48
Chemicals · Basic Materials
Exchange
NASDAQ Helsinki
Winston Score
48
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Strong
Stability
Strong
Valuation
Strong
Dividends
Exceptional

Winston Score History

The full picture

Kemira Oyj is a Finnish chemical company that makes specialty chemicals used to treat water and improve industrial processes. Its main products include chemicals for water treatment, pulp and paper production, and oil and gas operations. The company sells primarily to industrial customers like paper mills, municipal water utilities, and energy companies, making it a significant European supplier of process and water chemistry solutions.

Kemira earns revenue by selling chemical products directly to industrial customers, with pricing tied to both raw material costs and the value those chemicals deliver in improving efficiency or meeting environmental standards. The company operates mainly in Europe and North America, with annual revenues around €3 billion, and its competitive edge comes from long-term customer relationships and technical expertise in formulating chemicals for specific industrial needs. The key growth driver is tightening global water regulations, which push more industrial and municipal customers to invest in water treatment — but rising raw material costs remain a persistent risk to profit margins.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
10.4%
Thin — 10.4% gross margin
Profit after running costs
Operating Margin
8.9%
Modest — 8.9% operating margin
Return on the money invested
ROCE
10.7%
Below par — 10.7% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-4.6%
Shrinking sales (-4.6% YoY)
Profit growth
EPS YoY
-33.1%
Earnings shrinking (-33.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
1/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
283%
Turns 283% of profit into real cash
Spare cash per sale
FCF Margin
7.6%
Modest free cash flow (7.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.41
Conservative — low debt load (0.41)
Covers its interest
Interest Cover
9.16x
Comfortably covers interest (9.2x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
17.8x
no trend
Fair value — P/E 17.8

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+6.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (17.8 → 10.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
4.41%
no trend
Healthy income — 4.41% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
+15.4%
no trend
Dividend growing fast (15.4% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial